Current Questions in HIV-Associated Lung Cancer

por Shcherba, Marina, Shuter, Jonathan, Haigentz, Missak
Publicado 2013

Lung Cancer in HIV Infection

por Mani, Deepthi, Haigentz, Missak, Aboulafia, David M
Publicado 2011

Dermatologic Toxicities from Monoclonal Antibodies and Tyrosine Kinase Inhibitors against EGFR: Pathophysiology and Management

por Abdullah, Shaad E., Haigentz, Missak, Piperdi, Bilal
Publicado 2012

AHNS Series: Do you know your guidelines? Principles of Treatment for Locally Advanced or Unresectable Head and Neck Squamous Cell Carcinoma

por Fulcher, Cory D., Haigentz, Missak, Ow, Thomas J.
Publicado en Head Neck (2017)

EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab

por Kono, Scott A., Haigentz, Missak, Yom, Sue S., Saba, Nabil
Publicado 2012

Monoclonal Antibodies against Epidermal Growth Factor Receptor in Solid Tumors

por Saba, Nabil F., Yom, Sue S., Haigentz, Missak, El-Rayes, Bassel
Publicado 2012

Association between malignancy and non-alcoholic Wernicke's encephalopathy: a case report and literature review

por Choi, Evan Y., Gomes, William A., Haigentz, Missak, Graber, Jerome J.
Publicado en Neurooncol Pract (2016)

Head and Neck Squamous Cell Carcinomas in HIV-Positive Patients: A Preliminary Investigation of Viral Associations

por McLemore, Michael S., Haigentz, Missak, Smith, Richard V., Nuovo, Gerard J., Alos, Llucia, Cardesa, Antonio, Brandwein-Gensler, Margaret
Publicado 2010

Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression i...

por Gilbert, Jill, Lee, Ju Whei, Argiris, Athanassios, Haigentz, Missak, Feldman, Lawrence Eric, Jang, Minyoung, Arun, Pattatheyil, Van Waes, Carter, Forastiere, Arlene A.
Publicado 2012

Risk of Cancer among Commercially Insured HIV-Infected Adults on Antiretroviral Therapy

por Lee, Jeannette Y., Dhakal, Ishwori, Casper, Corey, Noy, Ariela, Palefsky, Joel M., Haigentz, Missak, Krown, Susan E., Ambinder, Richard F., Mitsuyasu, Ronald T.
Publicado en J Cancer Epidemiol (2016)

Continuous Activity Monitoring during Concurrent Chemoradiotherapy

por Ohri, Nitin, Kabarriti, Rafi, Bodner, William R, Mehta, Keyur J, Shankar, Viswanathan, Halmos, Balazs, Haigentz, Missak, Rapkin, Bruce, Guha, Chandan, Kalnicki, Shalom, Garg, Madhur
Publicado en Int J Radiat Oncol Biol Phys (2016)

Targeting the EGFR and immune pathways in squamous cell carcinoma of the head and neck (SCCHN): forging a new alliance

por Saba, Nabil F, Chen, Zhuo Gerogia, Haigentz, Missak, Bossi, Paolo, Rinaldo, Alessandra, Rodrigo, Juan P, Mäkitie, Antti A., Takes, Robert P, Strojan, Primoz, Vermorken, Jan B, Ferlito, Alfio
Publicado en Mol Cancer Ther (2019)

Human Papillomavirus-Associated Head and Neck Squamous Cell Carcinoma Survival: A Comparison by Tumor Site and Initial Treatment

por Salazar, Christian R., Smith, Richard V., Garg, Madhur K., Haigentz, Missak, Schiff, Bradley A., Kawachi, Nicole, Anayannis, Nicole, Belbin, Thomas J., Prystowsky, Michael B., Burk, Robert D., Schlecht, Nicolas F.
Publicado 2013

Contemporary management of cancer of the oral cavity

por Genden, Eric M., Ferlito, Alfio, Silver, Carl E., Takes, Robert P., Suárez, Carlos, Owen, Randall P., Haigentz, Missak, Stoeckli, Sandro J., Shaha, Ashok R., Rapidis, Alexander D., Rodrigo, Juan Pablo, Rinaldo, Alessandra
Publicado 2010

Tracheostomy during SARS‐CoV‐2 pandemic: Recommendations from the New York Head and Neck Society

por Miles, Brett A., Schiff, Bradley, Ganly, Ian, Ow, Thomas, Cohen, Erik, Genden, Eric, Culliney, Bruce, Mehrotra, Bhoomi, Savona, Steven, Wong, Richard J., Haigentz, Missak, Caruana, Salvatore, Givi, Babak, Patel, Kepal, Hu, Kenneth
Publicado en Head Neck (2020)

A Phase II, Open-Label Study of Ramucirumab in Combination with Paclitaxel and Carboplatin as First-Line Therapy in Patients with Stage IIIB/IV Non–Small-Cell Lung Cancer

por Camidge, D. Ross, Berge, Eamon M., Doebele, Robert C., Ballas, Marc S., Jahan, Thierry, Haigentz, Missak, Hoffman, David, Spicer, James, West, Howard, Lee, Pablo, Yang, Ling, Joshi, Adarsh, Gao, Ling, Yurasov, Sergey, Mita, Alain
Publicado 2014

A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma

por Gilbert, Jill, Schell, Michael J., Zhao, Xiuhua, Murphy, Barbara, Tanvetyanon, Tawee, Leon, Marino E., Hayes, D. Neil, Haigentz, Missak, Saba, Nabil, Nieva, Jorge, Bishop, Justin, Sidransky, David, Ravi, Rajani, Bedi, Atul, Chung, Christine H.
Publicado en Oral Oncol (2015)

Response assessment after induction chemotherapy for head and neck squamous cell carcinoma: From physical examination to modern imaging techniques and beyond

por de Bree, Remco, Wolf, Gregory T., de Keizer, Bart, Nixon, Iain J., Hartl, Dana M., Forastiere, Arlene A., Haigentz, Missak, Rinaldo, Alessandra, Rodrigo, Juan P., Saba, Nabil F., Suárez, Carlos, Vermorken, Jan B., Ferlito, Alfio
Publicado en Head Neck (2017)

A phase I/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy (HAART) in HIV-positive patients with cancer: AIDS Malignancy Consortium Trial...

por Rudek, Michelle A, Moore, Page C., Mitsuyasu, Ronald T., Dezube, Bruce J., Aboulafia, David, Gerecitano, John, Sullivan, Ryan, Cianfrocca, Mary E., Henry, David H., Ratner, Lee, Haigentz, Missak, Dowlati, Afshin, Little, Richard F., Ivy, S. Percy, Deeken, John F.
Publicado 2014

The Current Role of Salvage Surgery in Recurrent Head and Neck Squamous Cell Carcinoma

por Hamoir, Marc, Schmitz, Sandra, Suarez, Carlos, Strojan, Primoz, Hutcheson, Kate A, Rodrigo, Juan P, Mendenhall, William M, Simo, Ricard, Saba, Nabil F, D‘Cruz, Anil K, Haigentz, Missak, Bradford, Carol R, Genden, Eric M, Rinaldo, Alessandra, Ferlito, Alfio
Publicado en Cancers (Basel) (2018)